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INTRODUCTION
Despite its recognition as a distinct entity for almost 100years, the syndrome commonly referred to as AmnioticFluid Embolism (AFE) remains one of the mostdevastating conditions in obstetrics.1 AFE is a rarecondition and a lethal complication of pregnancy andpuerperium. Because of this very rarity, and the fact thatit is a diagnosis of exclusion, the true incidence is difficultto determine. Combined with internationally differingdefinitions of AFE as well as differing methodologies forreporting and recording data, this results in a great rangeof reported incidence rates between countries. TheInternational Network of Obstetric Survey Systems(INOSS) has recently produced a consensus definitionof AFE as 'an acute cardio-respiratory collapse within 6hours after labour, birth or ruptured membranes, with noother identifiable cause, followed by acute coagulopathyin those women who survive the initial event,' and hasrecommended its use in future.2
Its presentation varies from cardiac or circulatoryshutdown to sudden death with varying degrees ofmultiple organ dysfunction. Approximately 47% ofwomen who experience AFE have a prior sign or symptombefore collapse. Commonly reported premonitorysymptoms include tingling sensation or numbness,agitation or breathlessness, lightheadedness, chest painor complain of feeling cold. Almost 36% of patients hadfetal compromise before any change in maternal
condition, likely due to compensated or unrecognisedmaternal hypoxia and hypotension. Cardiac arrest as apresenting feature is recorded in 60-80% of registeredcases.2
AFE appears to involve an abnormal activation ofhumoral and immunologic mechanisms leading to amassive inflammatory reaction following the entry offetal cells (antigens) into the maternal circulation.3 It islargely a clinical "diagnosis of exclusion" and, therefore,requires high level of suspicion. At present, there is noany specific antemortem test for diagnosis of thissyndrome. It is commonly diagnosed retrospectively andis primarily clinical diagnosis. Postmortem presence offetal debris or squamous cells in the maternal pulmonarycirculation remains a key diagnostic requirement, but isnot found in every case.
The management of pregnant women with suspicion ofAFE remains largely supportive and is directed atreversing any observable physiological abnormalities,with primary correction of oxygenation, coagulopathyand circulatory support. Once the patient presents withcollapse, the basic principles of ABCd resuscitationshould apply, with "d" representing delivery of the fetusin this case. A multidisciplinary team approach includingsenior obstetricians, midwives, anaesthetists, criticalcare team, intensivists, and haematologists is the key tosuccess. Several studies have now highlighted theassociation between neonatal outcome and timing ofdelivery in relation to the onset of AFE. The overall UKperinatal mortality rate in AFE is reported as 67 per1000. The morbidity of AFE for the baby is also reflectedin high rates of NICU admission, ventilation, encephalo-pathy, and long-term morbidity.2
The recurrence rate of AFE is unknown because of theextremely low incidence and high mortality rate of thecondition. No cases of recurrence have been reportedin the literature, but many cases of straightforward
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subsequent pregnancies have been reported. So, whilstpatients can be reassured to some degree whenplanning future pregnancies, they should also becounselled that the available sample size does not allowdefinitive conclusions regarding the risk of recurrence.2A recent, retrospective review by Dildy et al. found thatout of 105 women who had survived AFE, only 22% hadgone on to conceive again; and of those, who had notconceived, 61% had chosen not to do so due to a fear ofrecurrent AFE.
CASE REPORT
A 21-year healthy primigravida, height 163 cm, weighing62 kgs, presented at 36 weeks of gestation in labourroom with rupture of membranes since morning and mildlabour pain. When received in our triage area, she waswell oriented and vitally stable (blood pressure 120/80mmHg and pulse 82 bpm). Fetal heart beat at the timeof presentation was 140bpm and fetus showed areactive cardiotocograph. On vaginal examination, itwas 2 cm dilated, draining clear liquor.
Suddenly, patient had a generalised tonic-clonic fit withupward rolling of eyes and frothing from mouth. Fit wasself-limiting, followed by sudden maternal collapse. Shebecame pulseless and no blood pressures wererecordable. Immediate cardiopulmonary resuscitation(CPR) was initiated and patient intubated. She revivedbut soon crashed again. A second episode of CPR wasstarted and patient revived. Simultaneously, on perabdominal examination, there was sustained uterinecontraction and fetal heart beat showed bradycardia of65 bpm, which necessitated the need for cesareansection. Patient was rushed to operating room foremergency cesarean section with continuous bagging;and a limp baby boy of 2.9 kgs was born with an Apgarscore of 2/1 and 7/5 min. Baby was handed over topediatrician for resuscitation. The vital signs of thepatient in the operation room (OR) were 100/60 mmHgof blood pressure, 150 bpm of heart rate, and 100% ofoxygen saturation on high ventilatory parameters. Herarterial blood gases at the time of intubation were pH6.78, PCO2O, 11.8, PO2 13, and O2 saturation 48%. Shewas administered norepinephrine infusion at 0.15µg/kg/min for hypotension intraoperatively. Intra-operatively, patient developed uterine atony and startedbleeding from uterine stitch line and developedexcessive oozing, secondary to disseminated intra-vascular coagulation (DIC). Further laboratory testswere performed that showed the presence of severecoagulopathy with values of prothrombin time (PT) >120s (normal 10.5-13.5 s), activated partial thromboplastictime (APTT) >120 s (normal: 21-36 s), INR >9.0,D-dimer 3.3 mg/L (normal <0.2 mg/L) and fibrinogen, 0.5g/dl (normal; 1.5-4.0 g/dl), fibrinogen degenerationproduct (FDP) >20 µg/L (normal; 0-4 µg/L). Her plateletcount was initially 104 x 109/l. Massive transfusion protocol
was initiated and a total of 6 packed cell volumes (PCV),10 fresh frozen plasma (FFP), 10 platelet, and 6cryoprecipitates were transfused intraoperatively, in theimmediate post-operative period. With immediate andrapid blood products replacement, uterine atony andbleeding from stitch line improved markedly and acondom catheter uterine tamponade was inserted with400 ml of distilled water and vagina was packed with 2ribbon gauzes. The total duration of operation was 3hours; the urinary output was 800 ml with 3000 ml ofblood loss. The fluid input was 2000 ml; and 3650 ml ofblood was transfused. Her chest radiography showedincreased hilar markings and possibility of pulmonaryedema.
Postoperatively, patient was shifted to intensive care unit(ICU). Hemodynamic stability was achieved and herurinary outputs were satisfactory after mild initialhematuria. She remained in ICU for one day and wasextubated on 1st postoperative day. Transthoracicechocardiography was performed which revealednormal cardiac chambers, ejection fraction of 50%,mildly reduced right ventricular systolic function, andmoderate tricuspid regurgitation. Next day, she wasshifted to special care unit. During ICU stay, MRI brainwas performed showing no evidence of posteriorreversible encephalopathy syndrome (PRES), cerebralvenous sinus thrombosis (CVST). No additionalsignificant abnormality was noted. CT did notdemonstrate a pulmonary embolism. A diagnosis of AFEwas made. Both baby and mother were discharged instable condition on 6th postoperative day. On 2 weekspost-natal follow-up in clinic, both mother and baby werehealthy and stable. There were no observed neurologicalsequelae as well.
DISCUSSIONAFE is notified among the five major causes of directmaternal deaths in the UK with other includingeclampsia, pulmonary embolism, severe sepsis andperipartum haemorrhage.4,5 It is a rare but devastatingcomplication of pregnancy with incidence of approximately1 in 40,000 deliveries.1,3,6 The reported mortality rate ofthe condition ranges from 20% to 60%.1,3 The diagnosisof AFE is largely a "diagnosis of exclusion".3 Itspathogenesis can be broadly classified into threesubtypes: (1) The mechanical obstruction subtype -which is the actual embolization of the maternalpulmonary vasculature,3 (2) The anaphylactic subtype -in which there is anaphylactic reaction with idiosyncraticadverse response and massive postpartum hemorrhage,(3) The DIC subtype with a massive post-partumhaemorrhage. Each subtype has a separate pattern ofclinical signs and symptoms with varying severity of thedisease. Wide range of mortality and survival is affectedby the specific subtype.7-9
Management is largely supportive with an inter-disciplinary team effort that comprises prompt and
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aggressive hemodynamic resuscitation including timelyfluid and blood component replacement with correctinghemostatic disorders and provision of end-organ supportwith timely delivery of the fetus to aid in resuccitationand decreasing fetomaternal compromise.3
A team effort and multidisciplinary care can haveprofound effect on the outcomes. For the past 10 years,medical error and patient safety in the course of patientcare has gained significant attention. Obstetricemergencies usually involve low risk and young patientsand require a very efficient chain of multidiciplinary teameffort to improve outcomes. A key to success is thetimely intervention, sometimes referred to as "TheGolden Hour" in the management. As in this case, timelyrecognition of the collapse with urgent involvement ofthe anesthesia team and cesarean delivery of the fetuswithin 5 mins of CPR were the hallmarks.
To be more precise, a very well coordinated and time-sensitive response to an obstetric emergency is requiredfor improving outcomes. The role of local trainingprogrammes on individual basis in the management ofmaternal collapse cannot be denied and are conductedfrequently. However, more recently, there has been ahuge debate on simulation training in obstetricemergencies and the emerging results are worth it. Itinvolves training of a multiprofessional team involved inthe care rather than on individual basis and simulates anemergency without any harm to real patients.
Few articles, evaluating the effect of teamwork trainingwith simulation models, have been published; and evenfewer have examined objective measurements ofimprovement in the management of acute obstetricemergencies.4 In a multicentre randomised clinical trialin The Netherlands, they found a significant improvementin team performance and a significant increase in theuse of new medical technical skills 8 months afterobstetric, multiprofessional team training in a medicalsimulation centre.5
There is paucity in the literature on the role of effectiveteamwork in the management of AFE owing to the rarityof its occurence. However, some case reports havebeen published internationally showing successfuloutcomes with prompt detection and aggressivemanagement. A case reported in India in which a 27-yearprimipara had AFE during the peripartum period, inwhich due to expeditious CPR, both the mother and thenewborn survived.6
Many survivors do present with some degree ofneurological impairment. The rate of perinatal death withAFE approximates 25%, and 50% of surviving neonatesare neurologically intact. A study in UK included womenwith a diagnosis of AFE from February 2005 to January2014. It concluded that for every one woman who dies
because of AFE, four survive. Among the survivingwomen with AFE, 7% display permanent neurologicinjury. The women who survived with AFE without anypermanent neurologic injury, 17% had other majormorbidity.9 For counselling regarding subsequentpregnancies, it is worth knowing that to date a total of 12cases of successful pregnancy after survival from AFEhave been reported in the literature with no case ofrecurrence of AFE.10 A retrospective case study in Japan,including 10 AFE patients, showed a maternal mortalityrate of 70%.11
AFE is rare but potentially devastating syndrome thatmanifests mainly during or around delivery. Immediateresuscitation and interdisciplinary approach, with activecardiopulmonary stabilization, hemodynamic correction,early vasopressor use, correction of hemostaticdisorders and undelayed cesarean delivery, plays aimportant role in the outcome.
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